CLINICAL_TRIALS
trial_result
· 2023-02-06
Clinical Trial Update: Sargramostim Use in COVID-19 to Recover Patient Health [Phase 2]
Summary
A Phase 2 trial evaluating sargramostim for recovery in COVID-19 patients has completed with results posted in early 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Partner Therapeutics, Inc. | Conditions: Covid19, SARS-CoV Infection | Phase 2 | Status: COMPLETED | Results posted: 2023-02-06